3 Mid-Cap Growth Stocks With Monstrous Long-Term Upside
Investing in stocks with modest valuations can set investors up for some significant returns in the long run. While there is more risk involved in putting money into smaller, less-established businesses, the upside can also be considerable, potentially resulting in massive gains.
Three mid-cap stocks that may have a lot of room to rise higher in the future are Archer Aviation (NYSE: ACHR), CRISPR Therapeutics (NASDAQ: CRSP), and e.l.f. Beauty (NYSE: ELF). Here are the big risks and opportunities that come with these stocks.
Image source: Getty Images.
Source Fool.com
CRISPR Therapeutics AG Stock
€41.63
-1.050%
With 0 Sell predictions and 2 Buy predictions the community sentiment towards the CRISPR Therapeutics AG stock is not clear.
Based on the current price of 41.63 € the target price of 200 € shows a potential of 380.48% for CRISPR Therapeutics AG which would more than double the current price.
